Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel azide-free synthesis route for Oseltamivir phosphate ensuring safety and scalability for global pharmaceutical supply chains.
Novel azide-free route for cephalosporin intermediates. High purity scalable process reduces supply chain risks for pharmaceutical manufacturing partners globally.
Patent CN108675960B reveals Cu-catalyzed route for 6-difluorophenanthridines. Offers high purity, scalable pharma intermediate manufacturing with cost efficiency.
Patent CN106083707A reveals a catalyst-free synthesis for heteroaryl sulfides. Discover cost reduction in pharmaceutical intermediate manufacturing and supply chain reliability.
Patent CN115197058A reveals a novel total synthesis of anticancer Dysideanone B. Discover cost-effective manufacturing routes and supply chain advantages for pharmaceutical intermediates.
Novel continuous flow quaternization technology ensures high purity cyclic ammonium salts. Reduces reaction time significantly compared to batch methods for reliable supply.
Novel method for anti-tumor trans-stilbene compounds avoiding cis-isomers. High yield, scalable process for pharmaceutical intermediates.
Novel bio-chemical route for phenylephrine ensures high purity and cost efficiency for pharmaceutical supply chains globally via patented enzymatic reduction.
Patent CN101993420A reveals a high-yield route for HIV drug intermediates, offering cost reduction and scalable manufacturing for global pharma supply chains.
Novel preparation method for N6-Bz-A-S-GNA phosphoramidite ensures high purity and scalability. Cost-effective solution for oligonucleotide manufacturing supply chains.
Patent CN108047139B details a novel synthesis route for chalcone-benzimidazole salts, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN108178736A reveals efficient silver-catalyzed route. Enables cost reduction in pharmaceutical intermediates manufacturing with scalable processes.
Novel purification method for Crisaborole reduces impurities below 0.05% and simplifies solvent usage, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Novel room-temperature acid hydrolysis of scutellarin yields high-purity scutellarein without organic solvents, offering significant cost and supply chain advantages.
Novel Lewis acid catalyzed route offers high purity 2-aminoindan with reduced cost and enhanced safety for scalable pharmaceutical intermediate manufacturing supply chains.
Novel azide ring-opening route for Ticagrelor Intermediate C. Reduces steps, improves purity, ensures supply chain stability for API manufacturing.
Novel biocatalytic route for L-carnitine production offers >99% ee, reduced toxicity, and scalable manufacturing for reliable pharmaceutical intermediate supply chains.
Patent CN103044482A reveals a novel organotin anticancer agent with superior liposolubility. Discover cost-effective manufacturing routes for high-purity pharmaceutical intermediates.
Patent CN107556355A reveals novel AcO-MMT-Cl route for high-purity nucleoside phosphoramidites. Enhances supply chain reliability and reduces purification costs significantly.
Patent CN107176952A details a novel synthesis route for key pharmaceutical intermediates offering improved yield and supply chain stability for global procurement teams.